Auditor Resigns Amidst Going Concern Warning; New Firm Appointed
GRVE has more than doubled off its 52-week low of $0.001 on light trading volume (0.2× avg).
Summary
GROOVE BOTANICALS INC. reported the resignation of its independent auditor, M. S. Madhava Rao, and the immediate appointment of GSKCA & Associates, with no disagreements cited.
Key Events · Corporate Governance and Compliance · GRVE
-
Auditor Resignation
M. S. Madhava Rao, Chartered Accountant, resigned as the independent registered public accounting firm on May 13, 2026. No reason for the resignation was provided by the auditor.
-
No Disagreements Reported
The company stated there were no disagreements with the former auditor on accounting principles or practices, financial statement disclosure, or auditing scope during the past two fiscal years and interim period.
-
Going Concern Paragraph
The former auditor's reports for fiscal years 2025 and 2024 included an explanatory paragraph regarding substantial doubt about the company's ability to continue as a going concern, consistent with prior disclosures.
-
New Auditor Appointed
Concurrently with the resignation, the Board of Directors approved the engagement of GSKCA & Associates as the new independent registered public accounting firm, effective May 13, 2026.
Analysis · GRVE · Energy & Transportation
GROOVE BOTANICALS INC., a company already facing a going concern warning and critically low cash, announced the resignation of its independent auditor, M. S. Madhava Rao. While the auditor did not provide a reason for the resignation, the company stated there were no disagreements on accounting principles or reportable events. A new firm, GSKCA & Associates, was immediately appointed. This change is important for maintaining compliance, especially given the company's precarious financial state, where any disruption to financial reporting could exacerbate existing challenges.
At the time of this filing, GRVE was trading at $0.01 on OTC in the Energy & Transportation sector, with a market capitalization of approximately $552.8K. The 52-week trading range was $0.00 to $0.30. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.